June 23 (Reuters) - Drugmaker SIGA Technologies said on Thursday it has received orders worth about $13 million for its oral antiviral drug Tpoxx, as monkeypox cases spread globally. (Reporting by Leroy Leo in Bengaluru; Editing by Amy Caren Daniel)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.56 USD | +0.71% | -4.04% | +52.86% |
Mar. 13 | North American Morning Briefing : Stock Futures Flat After S&P 500 Hit Record High | DJ |
Mar. 12 | Tranche Update on SIGA Technologies, Inc.'s Equity Buyback Plan announced on August 5, 2021. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.86% | 609M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock SIGA Technologies, Inc. - Nasdaq
- News SIGA Technologies, Inc.
- Siga Technologies gets orders worth $13 mln for antiviral drug